Prevalence of Ocular Manifestations in Inflammatory Rheumatic Diseases
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5,000
- 主要终点
- Prevalence of ocular manifestations of inflammatory rheumatic diseases
研究概览
简要总结
This is a search strategy for determining the prevalence of ocular complications in inflammatory rheumatic diseases for the purposes of a meta analysis.
详细描述
For the purposes of determining the prevalence of ocular complications in inflammatory rheumatic diseases, the following search terms were used: conjunctivitis, keratoconjunctivitis sicca, xerophthalmia, uveitis, eye hemorrhage, optic neuritis, papilledema, orbital disease, retinal artery/vein occlusion, macular edema, retinitis, chorioretinitis, scleritis, iridocyclitis, choroid hemorrhage, blindness and amaurosis fugax.
These terms were searched in the context of a corresponding inflammatory disease on Medline, Cochrane and Web of Science from their inception (1966, 1991 and 1990 respectively) until the point of study completion.
Studies were included if they provided numerical data of the prevalence or incidence of ocular manifestations in an inflammatory rheumatic disease. Studies were excluded if they were review articles, case reports where all patients experienced the same ocular comorbidity, if different comorbidities were not grouped independently, and if the study reported on fewer than 20 patients. When the same study cohort was used in more than one analysis, the most recent or largest sample-size study was included. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist was used to assess the quality of cohort, case-control, and cross-sectional studies.
研究设计
- 研究类型
- Observational
- 观察模型
- Ecologic Or Community
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Studies were included if they provided numerical data of the prevalence or incidence of ocular manifestations in inflammatory rheumatic disease
排除标准
- •review articles,
- •case reports where all patients experienced the same ocular comorbidity
- •if different comorbidities were not grouped independently
- •if the study reported on fewer than 20 patients
结局指标
主要结局
Prevalence of ocular manifestations of inflammatory rheumatic diseases
时间窗: data is collected once per year up to 2020
Prevalence of ocular manifestations of inflammatory rheumatic diseases
次要结局
未报告次要终点
研究者
Janet Pope
Professor of Medicine
Lawson Health Research Institute
